Anthony Nolan – Our Stories

Saving the Lives of People with Blood Cancer

  • Home
  • Patient Services & Insight
  • Supporter Stories
  • Science & Policy
  • Donor Stories
What factors should you consider when identifying a cell source provider?

What factors should you consider when identifying a cell source provider?

Katie GriffeeDecember 17, 2020 by Katie Griffee

Through the Anthony Nolan Cell & Gene Therapy Service’s provision of cellular material to cell and gene therapy researchers, we are familiar with industry standards and clients’ requirements. But we wanted to find out more about what drives decision making when selecting a cell source provider, and set out the key questions you should be…

Read more >

Filed Under: Cell & Gene Therapy

HENNY BRAUND: WHAT DOES THE FUTURE HOLD FOR STEM CELL TRANSPLANT RECIPIENTS?

HENNY BRAUND: WHAT DOES THE FUTURE HOLD FOR STEM CELL TRANSPLANT RECIPIENTS?

Henny BraundNovember 24, 2020 by Henny Braund

Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best chance of life. This blog post is adapted from an interview recently given by Henny Braund for The Economist’s World Cancer Series: Europe Virtual Week. You can watch…

Read more >

Filed Under: Patient Services & Insight, Scientific Research

Cord blood: an under-utilised source of hematopoietic cells

Cord blood: an under-utilised source of hematopoietic cells

Diana HernandezOctober 6, 2020 by Diana Hernandez

Umbilical cord blood (UCB) has huge potential, not only as a successful alternative source of hematopoietic blood cells for transplant/clinical application, but in research and development too. However, too often UCB is overlooked and seen as just an alternative, leaving it an under-utilised resource.  UCB in transplantation The advantages of UCB as a source of…

Read more >

Filed Under: Cord blood, Scientific Research

The journey of a cell for research

The journey of a cell for research

Jonathan KayAugust 26, 2020 by Jonathan Kay

For over 45 years Anthony Nolan has recruited potential stem cell donors to their register – people who are willing to donate their cells to someone in need of a lifesaving stem cell transplant. As this work continues, in parallel we apply our vast experience and dedicated team of experts to help develop new cell-based…

Read more >

Filed Under: Cell & Gene Therapy, Science & Policy, Scientific Research

Introducing: Anthony Nolan Cell & Gene Therapy Services

Introducing: Anthony Nolan Cell & Gene Therapy Services

Katie GriffeeAugust 18, 2020 by Katie Griffee

Cell and gene therapies have the potential to be transformative for patients. With the right support, researchers and developers have an opportunity to become leaders in this competitive global market. The number of allogeneic cell-based therapies in development is greater than ever, but how can organisations ensure they have a sustainable supply of starting material?…

Read more >

Filed Under: Cell & Gene Therapy

Is cord blood a better source of stem cells for some blood cancer patients in need of a transplant?

Is cord blood a better source of stem cells for some blood cancer patients in need of a transplant?

Jonathan KayJuly 30, 2020 by Jonathan Kay

In this blog, our Science Communications Manager, Jonathan Kay, looks at a recent study that highlights the potential benefits of selecting a cord blood transplant over a matched related donor for some patients with blood cancer. Introduction  When someone needs a stem cell transplant to treat their blood cancer or blood disorder, they can rely on organisations like…

Read more >

Filed Under: Cord blood, Donor Stories, Patient Services & Insight, Scientific Research

Next Page »

Recent News

What factors should you consider when identifying a cell source provider?

December 17, 2020 by Katie Griffee

HENNY BRAUND: WHAT DOES THE FUTURE HOLD FOR STEM CELL TRANSPLANT RECIPIENTS?

November 24, 2020 by Henny Braund

How can we personalise care in the digital era?

November 3, 2020 by Nusha Haghpanah

‘I was 6 months pregnant when I was told I needed a bone marrow transplant’ – Sophie’s story

November 3, 2020 by Clare McCrudden

Launching our report: Stem cell transplants and COVID-19: What have we learnt from patients during the pandemic?

October 29, 2020 by Charlotte Wickens

Post categories

  • Cell & Gene Therapy
  • Cord blood
  • Donor Stories
  • Patient Services & Insight
  • Science & Policy
  • Scientific Research
  • Supporter Stories
  • Uncategorized

Enter your email address to subscribe to this blog and get new posts via email

Links

  • Home
  • Patient Services & Insight
  • Supporter Stories
  • Science & Policy
  • Donor Stories

Follow Us

Terms & Conditions

Privacy Policy and Cookies

Anthony Nolan is a registered charity no 803716/SC038827 and a registered company no 2379280

© 2021 Anthony Nolan · anthonynolan.org